Related Experiment Video
Updated: May 15, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
[Immunotherapy targeting cancer stem cells]
Yutaka Kawakami1, Maiko Matsushita, Ryo Ueda
1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine.
Abstract:
Cancer stem cells are relatively resistant to chemotherapy, and cause relapse of cancer. Thus, various strategies to eliminate cancer stem cells have recently been exploited. One of them is immunotherapy. To develop the immunotherapy targeting cancer stem cells, tumor antigens expressed in cancer stem cells have been identified, and their use in the immunotherapy is expected. However, cancer stem cells may have an immunosuppressive ability. Therefore, blockade of the immunosuppressive mechanisms of cancer stem cells may also be required for development of effective immunotherapies against cancer stem cells.
Insights
Cancer stem cells (CSCs) resist chemotherapy and cause relapse. Immunotherapy targeting CSCs is promising, but their immunosuppressive abilities must be overcome for effective cancer treatment.
Area of Science:
- Oncology
- Immunology
- Cancer Stem Cell Biology
Background:
- Cancer stem cells (CSCs) are implicated in tumor recurrence and resistance to conventional therapies.
- Targeting CSCs is a critical strategy for improving cancer treatment outcomes.
- Immunotherapy presents a potential avenue for eliminating CSCs.
Purpose of the Study:
- To explore the potential of immunotherapy for eradicating cancer stem cells.
- To identify tumor antigens expressed by CSCs for targeted immunotherapy development.
- To investigate the immunosuppressive mechanisms employed by CSCs.
Main Methods:
- Identification of tumor antigens specific to cancer stem cells.
- Evaluation of immunotherapy strategies targeting these antigens.
- Analysis of the immunosuppressive properties of cancer stem cells.
Main Results:
- Tumor antigens expressed by CSCs have been identified.
- Immunotherapy approaches targeting CSCs are under development.
- CSCs possess immunosuppressive capabilities that may hinder treatment efficacy.
Conclusions:
- Effective immunotherapy against cancer requires addressing CSCs.
- Targeting CSC-specific antigens is a key strategy.
- Overcoming CSC-mediated immunosuppression is crucial for successful cancer immunotherapy.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

